RT @JACCJournals: #JACCIMG: A step beyond “high-risk plaque” through quantitative #YesCCT? In this study of serial YesCCT, baseline plaque…
RT @AChoiHeart: Important paper-moving beyond simply stenosis or ID of discrete high risk plaques, but ID of total non-obs quantified plaqu…
RT @ErinMichos: It's the total plaque burden not the type of plaque that matters most for risk. #SCCT2020 #yesCCT
RT @iamritu: Baseline PAV (percent atheroma volume) not HRP( high risk plaque) ≥2 : positive remodeling, spotty calcification, or low-at…
RT @ErinMichos: It's the total plaque burden not the type of plaque that matters most for risk. #SCCT2020 #yesCCT
RT @iamritu: Baseline PAV (percent atheroma volume) not HRP( high risk plaque) ≥2 : positive remodeling, spotty calcification, or low-at…
RT @ErinMichos: It's the total plaque burden not the type of plaque that matters most for risk. #SCCT2020 #yesCCT
RT @iamritu: Baseline PAV (percent atheroma volume) not HRP( high risk plaque) ≥2 : positive remodeling, spotty calcification, or low-at…
RT @ErinMichos: It's the total plaque burden not the type of plaque that matters most for risk. #SCCT2020 #yesCCT https://t.co/oL2QsugAzz
RT @ErinMichos: It's the total plaque burden not the type of plaque that matters most for risk. #SCCT2020 #yesCCT
RT @iamritu: Baseline PAV (percent atheroma volume) not HRP( high risk plaque) ≥2 : positive remodeling, spotty calcification, or low-at…
Differences in Progression to Obstructive Lesions per High-Risk Plaque Features and Plaque Volumes With CCTA - ScienceDirect https://t.co/jXoh3n7x4V
RT @iamritu: Baseline PAV (percent atheroma volume) not HRP( high risk plaque) ≥2 : positive remodeling, spotty calcification, or low-at…
RT @ErinMichos: It's the total plaque burden not the type of plaque that matters most for risk. #SCCT2020 #yesCCT
RT @ErinMichos: It's the total plaque burden not the type of plaque that matters most for risk. #SCCT2020 #yesCCT
RT @ErinMichos: It's the total plaque burden not the type of plaque that matters most for risk. #SCCT2020 #yesCCT https://t.co/oL2QsugAzz
RT @JCLRodrigues: Differences in Progression to Obstructive Lesions per High-Risk Plaque Features and Plaque Volumes With CCTA - ScienceDir…
RT @ErinMichos: It's the total plaque burden not the type of plaque that matters most for risk. #SCCT2020 #yesCCT https://t.co/oL2QsugAzz
RT @ErinMichos: It's the total plaque burden not the type of plaque that matters most for risk. #SCCT2020 #yesCCT
RT @iamritu: Baseline PAV (percent atheroma volume) not HRP( high risk plaque) ≥2 : positive remodeling, spotty calcification, or low-at…
Differences in Progression to Obstructive Lesions per High-Risk Plaque Features and Plaque Volumes With CCTA - ScienceDirect https://t.co/Tf4vz0gtNk
RT @iamritu: Baseline PAV (percent atheroma volume) not HRP( high risk plaque) ≥2 : positive remodeling, spotty calcification, or low-at…
RT @iamritu: Baseline PAV (percent atheroma volume) not HRP( high risk plaque) ≥2 : positive remodeling, spotty calcification, or low-at…
RT @iamritu: Baseline PAV (percent atheroma volume) not HRP( high risk plaque) ≥2 : positive remodeling, spotty calcification, or low-at…
Baseline PAV (percent atheroma volume) not HRP( high risk plaque) ≥2 : positive remodeling, spotty calcification, or low-attenuation plaque MOST important predictor of CAD lesions developing into obstructive lesions by #YesCCT https://t.co/HJ5BeeotzF
RT @AChoiHeart: Important paper-moving beyond simply stenosis or ID of discrete high risk plaques, but ID of total non-obs quantified plaqu…
RT @AChoiHeart: Important paper-moving beyond simply stenosis or ID of discrete high risk plaques, but ID of total non-obs quantified plaqu…
RT @JACCJournals: #JACCIMG: A step beyond “high-risk plaque” through quantitative #YesCCT? In this study of serial YesCCT, baseline plaque…
RT @AChoiHeart: Important paper-moving beyond simply stenosis or ID of discrete high risk plaques, but ID of total non-obs quantified plaqu…
RT @AChoiHeart: Important paper-moving beyond simply stenosis or ID of discrete high risk plaques, but ID of total non-obs quantified plaqu…
RT @JACCJournals: #JACCIMG: A step beyond “high-risk plaque” through quantitative #YesCCT? In this study of serial YesCCT, baseline plaque…
RT @AChoiHeart: Important paper-moving beyond simply stenosis or ID of discrete high risk plaques, but ID of total non-obs quantified plaqu…
RT @JACCJournals: #JACCIMG: A step beyond “high-risk plaque” through quantitative #YesCCT? In this study of serial YesCCT, baseline plaque…
RT @AChoiHeart: Important paper-moving beyond simply stenosis or ID of discrete high risk plaques, but ID of total non-obs quantified plaqu…
RT @AChoiHeart: Important paper-moving beyond simply stenosis or ID of discrete high risk plaques, but ID of total non-obs quantified plaqu…
Important paper-moving beyond simply stenosis or ID of discrete high risk plaques, but ID of total non-obs quantified plaque volume by #YesCCT predicts future obstructive CAD But..quantifying plaque is hard to do...can we improve how we eval total atheros
RT @JACCJournals: #JACCIMG: A step beyond “high-risk plaque” through quantitative #YesCCT? In this study of serial YesCCT, baseline plaque…
RT @JACCJournals: #JACCIMG: A step beyond “high-risk plaque” through quantitative #YesCCT? In this study of serial YesCCT, baseline plaque…
RT @JACCJournals: #JACCIMG: A step beyond “high-risk plaque” through quantitative #YesCCT? In this study of serial YesCCT, baseline plaque…
RT @JACCJournals: #JACCIMG: A step beyond “high-risk plaque” through quantitative #YesCCT? In this study of serial YesCCT, baseline plaque…
RT @JACCJournals: #JACCIMG: A step beyond “high-risk plaque” through quantitative #YesCCT? In this study of serial YesCCT, baseline plaque…
RT @JACCJournals: #JACCIMG: A step beyond “high-risk plaque” through quantitative #YesCCT? In this study of serial YesCCT, baseline plaque…
RT @JACCJournals: #JACCIMG: A step beyond “high-risk plaque” through quantitative #YesCCT? In this study of serial YesCCT, baseline plaque…
RT @JACCJournals: #JACCIMG: A step beyond “high-risk plaque” through quantitative #YesCCT? In this study of serial YesCCT, baseline plaque…
RT @JACCJournals: #JACCIMG: A step beyond “high-risk plaque” through quantitative #YesCCT? In this study of serial YesCCT, baseline plaque…
RT @JACCJournals: #JACCIMG: A step beyond “high-risk plaque” through quantitative #YesCCT? In this study of serial YesCCT, baseline plaque…
Differences in Progression to Obstructive Lesions per High-Risk Plaque Features and Plaque Volumes With CCTA | JACC: Cardiovascular Imaging https://t.co/8A3xkZA0YL
Differences in Progression to Obstructive Lesions per High-Risk Plaque Features and Plaque Volumes With CCTA. https://t.co/lpz9byOxJd